Use of Oxycodone in Pain Management
Open Access
- 22 April 2012
- journal article
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 1 (4) , 262-264
Abstract
Oxycodone is widely used to alleviate moderate-to severe acute pain, It is an effective analgesic for many types of pain, and is especially useful for paroxysmal spontaneous pain, steady pain, allodynia associated with postherpetic neuralgia, and it is also increasingly used in the management of cancer-related and chronic pain, oxycodone has been found to improve the quality of life of patients with many types of pain. In 2011, following chemical and physical manipulation, an extended-release form of oxycodone was developed in order to maintain its rate-controlling mechanism. This new formulation significantly improved analgesia among patients with moderate-to-severe chronic osteoarthritis pain with an adverse event profile similar to that of other opioids. The long-term safety and efficacy of extended-release form of oxycodone in relieving moderate-to-severe chronic pain has been demonstrated. In this study we discussed about different aspects of this drug in managing of various types of pain.Keywords
This publication has 26 references indexed in Scilit:
- Oxycodone lengthens reproductions of suprasecond time intervals in human research volunteersBehavioural Pharmacology, 2011
- High doses of oxycodone–naloxone combination may provide poor analgesiaSupportive Care in Cancer, 2011
- Efficacy and safety of an extended-release oxycodone (Remoxy®) formulation in patients with moderate to severe osteoarthritic painJournal of Opioid Management, 2011
- Oxycodone-related side effects: Impact on degree of bother, adherence, pain relief, satisfaction, and quality of lifeJournal of Opioid Management, 2011
- Morfin eller oksykodon tabletter mot smerter?Tidsskrift for Den norske legeforening, 2010
- Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational studyBritish Journal of Clinical Pharmacology, 2010
- Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 aloneBritish Journal of Clinical Pharmacology, 2010
- Oxycodone: a review of its use in the management of painCurrent Medical Research and Opinion, 2007
- OxycodoneJournal of Pain and Symptom Management, 2005
- The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantationJournal of Clinical Anesthesia, 1996